"Castleman Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Large benign, hyperplastic lymph nodes. The more common hyaline vascular subtype is characterized by small hyaline vascular follicles and interfollicular capillary proliferations. Plasma cells are often present and represent another subtype with the plasma cells containing IgM and IMMUNOGLOBULIN A.
| Descriptor ID |
D005871
|
| MeSH Number(s) |
C15.604.515.245 C20.683.515.250
|
| Concept/Terms |
Castleman Disease- Castleman Disease
- Angiofollicular Lymphoid Hyperplasia
- Angiofollicular Lymphoid Hyperplasias
- Hyperplasia, Angiofollicular Lymphoid
- Lymphoid Hyperplasia, Angiofollicular
- Castleman's Disease
- Angiofollicular Lymph Node Hyperplasia
- Hyperplasia, Giant Lymph Node
- Lymph Node Hyperplasia, Giant
- Angiofollicular Lymph Hyperplasia
- Angiofollicular Lymph Hyperplasias
- Hyperplasia, Angiofollicular Lymph
- Lymph Hyperplasia, Angiofollicular
- Castlemans Disease
- Disease, Castlemans
- Giant Lymph Node Hyperplasia
- Castleman's Tumor
- Castleman Tumor
- Castlemans Tumor
- Tumor, Castleman's
|
Below are MeSH descriptors whose meaning is more general than "Castleman Disease".
Below are MeSH descriptors whose meaning is more specific than "Castleman Disease".
This graph shows the total number of publications written about "Castleman Disease" by people in this website by year, and whether "Castleman Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 4 | 1 | 5 |
| 2018 | 2 | 2 | 4 |
| 2019 | 0 | 1 | 1 |
| 2020 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Castleman Disease" by people in Profiles.
-
Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes. Blood Rev. 2021 01; 45:100707.
-
In silico Insights on IL-6: A Potential Target for Multicentric Castleman Disease. Curr Comput Aided Drug Des. 2020; 16(5):641-653.
-
Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults. J Am Acad Dermatol. 2019 Jun; 80(6):1544-1549.
-
Usefulness of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) DNA Viral Load in Whole Blood for Diagnosis and Monitoring of KSHV-Associated Diseases. J Clin Microbiol. 2018 06; 56(6).
-
Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation. PLoS One. 2018; 13(5):e0197298.
-
Chronic oral lichenoid erosions revealing haematological malignancies. J Eur Acad Dermatol Venereol. 2018 Nov; 32(11):e402-e403.
-
Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas. Blood Adv. 2018 03 13; 2(5):481-491.
-
A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review. Ann Hematol. 2018 Mar; 97(3):401-407.
-
Follicular lymphoma with hyaline-vascular Castleman disease-like follicles and CD20 positive follicular dendritic cells. Pathology. 2017 Aug; 49(5):544-547.
-
Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease. Histopathology. 2017 Jun; 70(7):1114-1124.